Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Buy | $111.3 | SEC | |
| Buy | $109.8 | SEC | |
| AwardD | — | SEC | |
| AwardD | — | SEC | |
| ExerciseD | — | SEC | |
| AwardD | — | SEC | |
| Other | $297.5K | SEC | |
| Exercise | — | SEC | |
| Buy | $106.6 | SEC | |
| Buy | $105.3 | SEC | |
| Buy | $104 | SEC | |
| Buy | $103.2 | SEC | |
| ExerciseD | — | SEC | |
| Other | $216K | SEC | |
| AwardD | — | SEC | |
| Exercise | — | SEC | |
| Buy | $100.5 | SEC | |
| Buy | $99.6 | SEC | |
| Buy | $98.7 | SEC | |
| Buy | $97.6 | SEC | |
| Exercise | — | SEC | |
| AwardD | — | SEC | |
| ExerciseD | — | SEC | |
| Other | $656.3K | SEC | |
| Buy | $93.2 | SEC |